Triple‐negative breast cancer (TNBC) is an aggressive breast cancer subtype, which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER‐2).1 Here, ERBB2 is linked to breast cancer.